{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:28:50Z","timestamp":1787678930727,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd012093","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000}}],"reference-count":209,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012093.pub2","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:54:36Z","timestamp":1579902876000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Topical and device-based treatments for fungal infections of the toenails"],"prefix":"10.1002","author":[{"given":"Kelly","family":"Foley","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya K","family":"Gupta","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Versteeg","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Mays","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Xi'an Jiaotong-Liverpool University; Department of Public Health; 111 Ren'ai Road, Dushu Lake Higher Education Town Suzhou Industrial Park Suzhou Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny","family":"John","sequence":"additional","affiliation":[{"name":"Campbell Collaboration; New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"10.1002\/14651858.CD012093.pub2-BIB0001|cit1","unstructured":"ACTRN12614000946617 Kunzea oil for the management of fungal nail infection (toenail onychomycosis), a pilot randomised controlled trial www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=366923"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0002|cit2","unstructured":"ACTRN12614001238662 Evaluation of mastic paint in the treatment of nail disorders (onycholysis, onychomycosis, onychorrhexis) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12614001238662"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/phpp.12420","article-title":"Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails","volume":"35","author":"Alberdi","year":"2019","journal-title":"Photodermatology, Photoimmunology, and Photomedicine"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2133.2009.09414.x","article-title":"Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study","volume":"162","author":"Amichai","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13934","article-title":"Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial","volume":"173","author":"Auvinen","year":"2015","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012093.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","article-title":"An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis","volume":"23","author":"Baran","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000488606","article-title":"Ciclopirox hydroxypropyl chitosan: efficacy in mild-to-moderate onychomycosis","volume":"5","author":"Piraccini","year":"2019","journal-title":"Skin Appendage Disorders"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/14764172.2018.1502451","article-title":"Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis","volume":"21","author":"Bonhert","year":"2019","journal-title":"Journal of Cosmetic and Laser Therapy"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0009|cit9","first-page":"601","article-title":"Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole","volume":"38","author":"Buck","year":"1994","journal-title":"Journal of Family Practice"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s13555-018-0254-1","article-title":"Daily application of an aqueous, acidifying, peelable nail polish versus weekly amorolfine for topical onychomycosis treatment: a prospective, randomized, blinded trial","volume":"8","author":"Eertmans","year":"2018","journal-title":"Dermatology and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1468-3083.2011.04373.x","article-title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs","volume":"27","author":"Elewski","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1468-3083.2011.04373.x","article-title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs","volume":"27","author":"Elewski","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies (Erratum appears in Journal of the American Academy of Dermatology, 2014 Feb;70(2):399)","volume":"68","author":"Elewski","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012093.pub2-BIB0014|cit14","first-page":"815","article-title":"The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials","volume":"13","author":"Gupta","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies (Erratum appears in Journal of the American Academy of Dermatolology, 2014 Feb;70(2):399)","volume":"68","author":"Elewski","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012093.pub2-BIB0016|cit16","first-page":"815","article-title":"The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials","volume":"13","author":"Gupta","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/09546634.2017.1329510","article-title":"Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomised phase 3 studies","volume":"29","author":"Gupta","year":"2018","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0019|cit19","first-page":"168","article-title":"Planimetric post-hoc analysis of women with onychomycosis from tavaborole 5% phase III studies: evidence of greater improvements in patients with >50% baseline infection","volume":"17","author":"Pariser","year":"2018","journal-title":"Journal of Drugs in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/09546634.2017.1329510","article-title":"Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomised phase 3 studies","volume":"29","author":"Gupta","year":"2018","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0022|cit22","first-page":"168","article-title":"Planimetric post-hoc analysis of women with onychomycosis from tavaborole 5% phase III studies: evidence of greater improvements in patients with >50% baseline infection","volume":"17","author":"Pariser","year":"2018","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0023|cit23","unstructured":"EUCTR2005-005905-51 A phase II, single-centre, randomised, parallel-group, clinical study to investigate the tolerability of double blind ciclopirox nail product compared to double blind placebo nail product compared to single blind mycoster in subjects with mild to moderate onychomycosis www.clinicaltrialsregister.eu\/ctr-search\/search?query=2005-005905-51"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0024|cit24","unstructured":"EUCTR2006-000974-54 A multi-centre, randomized, parallel groups, vehicle and active controlled study of amorolfine 4% and 10% nail lacquer new formulation in the topical treatment of distal and lateral subungual toenail onychomycosis www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2006-000974-54"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0025|cit25","unstructured":"EUCTR2006-005895-42 A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails www.clinicaltrialsregister.eu\/ctr-search\/search?query=2006-005895-42"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0026|cit26","unstructured":"EUCTR2008-003215-13 A double-blind, randomized, multicenter, placebo-controlled phase 3 trial to prove the superiority of bifonazole vs. placebo after 4 weeks of onychomycosis treatment (as a follow-up of a 2 weeks treatment of non-surgical nail ablation of diseased nail matrix with a 40% urea paste) www.clinicaltrialsregister.eu\/ctr-search\/search?query=2008-003215-13"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0027|cit27","unstructured":"EUCTR2016-001242-25 An early phase development, partly blinded, positive and vehicle controlled, randomized, non-inferiority investigation of the pharmacokinetics, safety and efficacy of BB2603 cutaneous hand-pump spray versus Lamisil\u00ae spray and versus BB2603 vehicle hand-pump spray in subjects with onychomycosis and associated tinea pedis www.clinicaltrialsregister.eu\/ctr-search\/search?query=2016-001242-25"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012093.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012093.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012093.pub2-BIB0030|cit30","first-page":"AB148","article-title":"A randomized, controlled, dose-ranging study to assess the efficacy and safety of terbinafine HCl nail lacquer for onychomycosis","volume":"54","author":"Gupta","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4 S1","key":"10.1002\/14651858.CD012093.pub2-BIB0031|cit31","first-page":"AB105","article-title":"Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis","volume":"68","author":"Hartmane","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2013.12.024","article-title":"Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial","volume":"70","author":"Hollmig","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012093.pub2-BIB0033|cit33","first-page":"AB77","article-title":"Forty-two-week safety study of topical nanoemulsion (NB-002) for the treatment of mild to moderate distal subungual onychomycosis: a randomized, double-blind, vehicle-controlled trial","volume":"62","author":"Ijzerman","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000441569","article-title":"Ciclopirox 8% HPCH nail lacquer in the treatment of mild-to-moderate onychomycosis: a randomized, amorolfine controlled study using a blinded evaluator","volume":"1","author":"Iorizzo","year":"2016","journal-title":"Skin Appendage Disorders"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/jdv.13798","article-title":"Treating onychomycosis with the short-pulsed 1064-nm-Nd: YAG laser: results of a prospective randomized controlled trial","volume":"31","author":"Karsai","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2340\/00015555-2874","article-title":"Laser-assisted photodynamic therapy or laser-assisted amorolfine lacquer delivery for treatment of toenail onychomycosis: an open-label comparative study","volume":"98","author":"Koren","year":"2018","journal-title":"Acta Dermato-Venereologia"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0037|cit37","first-page":"519","article-title":"Clinical trial of nailcare capsule and creams in toenail tinea unguium infection","volume":"43","author":"Kumar","year":"2001","journal-title":"Bombay Hospital Journal"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000345105","article-title":"Efficacy, safety and tolerability of an optimized avulsion technique with onyster (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study","volume":"226","author":"Lahfa","year":"2013","journal-title":"Dermatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012093.pub2-BIB0039|cit39","first-page":"394","article-title":"Randomized, double-blind, parallel design trial to assess the efficacy and safety of terbinafine nail lacquer for the treatment of onychomycosis","volume":"19","author":"Lu","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0040|cit40","first-page":"313","article-title":"A double-blind, vehicle-controlled study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes","volume":"53","author":"Montana","year":"1994","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0041|cit41","unstructured":"NCT01080079 Efficacy and safety study of iontophoretic application of terbinafine gel in subjects with onychomycosis clinicaltrials.gov\/ct2\/show\/NCT01080079"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0042|cit42","unstructured":"NCT01145807 A randomized, double-blind, vehicle- and placebo-controlled, multicenter trial in patients with mild to moderate distal subungual toenail onychomycosis to investigate the efficacy, tolerability, and safety of twice daily application of TDT 067 for 48 weeks clinicaltrials.gov\/ct2\/show\/NCT01145807"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0043|cit43","unstructured":"NCT01246518 Efficacy and safety of two treatment regimens of topical MOB015 in adults with distal subungual onychomycosis clinicaltrials.gov\/ct2\/show\/NCT01246518"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0044|cit44","unstructured":"NCT01400594 Safety and efficacy study of HTU-520 in the treatment of distal subungual onychomycosis of the toenail clinicaltrials.gov\/ct2\/show\/study\/NCT01400594"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0045|cit45","unstructured":"NCT02022215 Efficacy and safety study of ME1111 in patients with onychomycosis clinicaltrials.gov\/ct2\/show\/NCT02022215"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0046|cit46","unstructured":"NCT02343627 Safety and efficacy of NVXT solution in mild to moderate fungal infection of the toenail clinicaltrials.gov\/ct2\/show\/NCT02343627"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0047|cit47","unstructured":"NCT02933879 Randomized, placebo-controlled, double-blind, parallel-group, multi-site phase 2b clinical study www.clinicaltrials.gov\/ct2\/show\/NCT02933879"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0048|cit48","unstructured":"NCT03141840 Clinical trial of topical ABL01 treatment of onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT03141840"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0049|cit49","unstructured":"NCT03289871 Clinical evaluation of the efficacy of a medical device in treatment of toenail onychomycosis clinicaltrials.gov\/ct2\/show\/record\/NCT03289871"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0050|cit50","unstructured":"Nijenhuis-Rosien L Kleefstra N Van Dijk PR Wolfhagen MJ Groenier KH Bilo HJ Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomised, quadruple-blind, sham controlled trial (LASER-1) Journal of the European Academy of Dermatology and Venereology 10.1111\/jdv.15601"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13063-015-0622-4","article-title":"Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomised, double-blind, controlled trial (LASER-1)","volume":"16","author":"Nijenhuis-Rosien","year":"2015","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12906-017-1970-2","article-title":"A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen\u00ae dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis","volume":"17","author":"Parekh","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353667","article-title":"A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis","volume":"227","author":"Paul","year":"2013","journal-title":"Dermatology"},{"issue":"14","key":"10.1002\/14651858.CD012093.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0028-1088372","article-title":"Double-blind clinical trial for evaluating the effectiveness and tolerability of Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. A comparative study with ciclopirox (Planta Med) 2008:October;74(12):1430-1435","volume":"74","author":"Romero-Cerecero","year":"2008","journal-title":"Planta Medica"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jep.2009.08.007","article-title":"Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis","volume":"126","author":"Romero-Cerecero","year":"2009","journal-title":"Journal of Ethnopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S0365-05962012000100002","article-title":"Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes","volume":"87","author":"Schalka","year":"2012","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/myc.12473","article-title":"Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays","volume":"59","author":"Sigurgeirsson","year":"2016","journal-title":"Mycoses"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"AB88","DOI":"10.1016\/j.jaad.2014.01.367","article-title":"A blinded review of the ongoing SOLUTION study, a phase 2b\/3 study of 2 dosing regimens of a novel 10% luliconazole solution in patients with onychomycosis","volume":"70","author":"Stein","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD012093.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1346-8138.1998.tb02474.x","article-title":"Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study","volume":"25","author":"Syed","year":"1998","journal-title":"Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-3156.1999.00396.x","article-title":"Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream","volume":"4","author":"Syed","year":"1999","journal-title":"Tropical Medicine & International Health"},{"issue":"9","key":"10.1002\/14651858.CD012093.pub2-BIB0061|cit61","first-page":"1124","article-title":"The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis","volume":"13","author":"Toledo-Bahena","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0062|cit62","first-page":"186","article-title":"Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study","volume":"12","author":"Tschen","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD012093.pub2-BIB0063|cit63","first-page":"1237","article-title":"Prospective efficacy and safety evaluation of laser treatments with real-time temperature feedback for fungal onychomycosis","volume":"12","author":"Waibel","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012093.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1346-8138.13816","article-title":"Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study","volume":"44","author":"Watanabe","year":"2017","journal-title":"Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09546634.2018.1509046","article-title":"Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis","volume":"30","author":"Abd El-Aal","year":"2019","journal-title":"Journal of Dermatological Treatment"},{"issue":"1080","key":"10.1002\/14651858.CD012093.pub2-BIB0066|cit66","first-page":"51","article-title":"Ciclopirox (Penlac) nail lacquer for onychomycosis","volume":"42","author":"Anonymous","year":"2000","journal-title":"Medical Letter on Drugs & Therapeutics"},{"issue":"1463","key":"10.1002\/14651858.CD012093.pub2-BIB0067|cit67","first-page":"35","article-title":"Tavaborole topical solution (Kerydin) for onychomycosis","volume":"57","author":"Anonymous","year":"2015","journal-title":"Medical Letter on Drugs & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09546634.2011.588191","article-title":"A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial","volume":"23","author":"Bassiri-Jahromi","year":"2012","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0069|cit69","first-page":"494","article-title":"Tea tree oil: Panacea or placebo?","volume":"8","author":"Bergstrom","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1439-0507.1971.tb03028.x","article-title":"Topical treatment of nail and skin infections with miconazole, a new broad-spectrum antimycotic","volume":"14","author":"Botter","year":"1971","journal-title":"Mykosen"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000488369","article-title":"Single-center, prospective, blinded study comparing the efficacy and compatibility of efinaconazole 10% solution in treating onychomycosis with and without concurrent nail polish use","volume":"5","author":"Canavan","year":"2018","journal-title":"Skin Appendage Disorders"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0072|cit72","first-page":"A4","article-title":"EcoNail\u2122 (5% econazole plus 18% SEPA\u00ae) nail lacquer in patients with severe onychomycosis: safety, local tolerability, and systemic exposure","volume":"125","author":"Chan","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD012093.pub2-BIB0073|cit73","first-page":"1414","article-title":"Evaluation of the therapeutic efficacy of tea tree oil in treatment of onychomycosis","volume":"9","author":"Dina","year":"2017","journal-title":"International Journal of Pharmacognosy and Phytochemical Research"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/09546634.2014.998607","article-title":"A comparative clinical and mycological study of Nd-YAG laser versus topical terbinafine in the treatment of onychomycosis","volume":"26","author":"El-Tatawy","year":"2015","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1439-0507.2012.02215.x","article-title":"Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study","volume":"55","author":"Emtestam","year":"2012","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0076|cit76","first-page":"62","article-title":"Topical treatment of superficial mycoses with clotrimazole","volume":"50 Suppl 1","author":"Fredriksson","year":"1974","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"P124","DOI":"10.1016\/j.jaad.2004.10.502","article-title":"Cost-effectiveness analysis comparing amorolfine and ciclopirox in the treatment of onychomycosis without matrix involvement","volume":"52","author":"Furtado","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jdv.13842","article-title":"Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial","volume":"31","author":"Gilaberte","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012093.pub2-BIB0079|cit79","first-page":"28","article-title":"Ciclopirox nail lacquer as an adjunct to oral terbinafine for toenail onychomycosis: interim results from a randomized controlled trial","volume":"19","author":"Gupta","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0080|cit80","first-page":"38","article-title":"Experience with nail lacquers containing amorolfine 5% and ciclopirox 8% in patients with onychomycosis. Abstract P-56. 85th BAD Annual Meeting 5-8th July 2005, Glasgow, UK","volume":"153","author":"Halmy","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0081|cit81","first-page":"62","article-title":"Pulsed infrared laser treatment for onychomycosis: Controlled, randomized, multi-centered trial (n = 155)","volume":"42","author":"Harris","year":"2010","journal-title":"Lasers in Surgery and Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2230.1988.tb01961.x","article-title":"The topical treatment of onychomycosis using a new combined urea\/imidazole preparation","volume":"13","author":"Hay","year":"1988","journal-title":"Clinical and Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0083|cit83","first-page":"11","article-title":"Comparison of therapy with 1% bifonazole plus 40% urea, monotherapy with 40% urea and placebo on patients with onychomycosis","volume":"62","author":"Jimenez-Faraj","year":"2018","journal-title":"Dermatologia Revista Mexicana"},{"issue":"12","key":"10.1002\/14651858.CD012093.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1439-0507.1980.tb01778.x","article-title":"Clotrimazole and econazole in dermatophytoses (a double blind study)","volume":"23","author":"Kamalam","year":"1980","journal-title":"Mycoses"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/14764172.2016.1157372","article-title":"The effectiveness of 1,064-nm long-pulsed Nd:YAG laser in the treatment of severe onychomycosis","volume":"18","author":"Kim","year":"2016","journal-title":"Journal of Cosmetic and Laser Therapy"},{"issue":"12","key":"10.1002\/14651858.CD012093.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/myc.12534","article-title":"A randomised comparative study of 1064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis","volume":"59","author":"Kim","year":"2016","journal-title":"Mycoses"},{"issue":"9","key":"10.1002\/14651858.CD012093.pub2-BIB0087|cit87","first-page":"734","article-title":"Topical antifungals for treatment of onychomycosis","volume":"94","author":"Krasaeath","year":"2016","journal-title":"American Family Physician"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7547\/1000166","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure","volume":"100","author":"Landsman","year":"2010","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7547\/1020169","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days","volume":"102","author":"Landsman","year":"2012","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2230.1992.tb00277.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly","volume":"17","author":"Lauharanta","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD012093.pub2-BIB0091|cit91","first-page":"1258","article-title":"Comparison of the efficacy of long-pulsed Nd:YAG laser intervention for treatment of onychomycosis of toenails or fingernails","volume":"13","author":"Li","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5021\/ad.2016.28.3.406","article-title":"The efficacy of prognostic factors for long-pulse neodymium: yttrium-aluminum-garnet laser treatment on onychomycosis: A pilot study","volume":"28","author":"Lu","year":"2016","journal-title":"Annals of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02093313","article-title":"Clinical trial with clotrimazole cream (Bay b 5097) in dermatophytosis and onychomycosis","volume":"56","author":"Mahgoub","year":"1975","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.jfas.2008.12.012","article-title":"Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial","volume":"48","author":"Malay","year":"2009","journal-title":"Journal of Foot & Ankle Surgery"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0095|cit95","first-page":"17","article-title":"Candida albicans onychomycosis- a study of five modes of therapy","volume":"3","author":"Many","year":"1964","journal-title":"Dermatologia Tropica Et Ecologica Geographica"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1111\/j.1439-0507.2010.01898.x","article-title":"Therapeutic efficacy of topical OLEOZON\u00ae in patients suffering from onychomycosis","volume":"54","author":"Men\u00e9ndez","year":"2011","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2230.1992.tb00274.x","article-title":"Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations","volume":"17","author":"Mensing","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0098|cit98","first-page":"359","article-title":"Open-label study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes","volume":"49","author":"Meyerson","year":"1992","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jphotobiol.2017.06.010","article-title":"Photodynamic therapy treatment of onychomycosis with aluminium-phthalocyanine chloride nanoemulsions: A proof of concept clinical trial","volume":"173","author":"Morgado","year":"2017","journal-title":"Journal of Photochemistry and Photobiology. B, Biology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0100|cit100","unstructured":"NCT03094468 Study to evaluate the efficacy and safety of P-3058 nail solution in the treatment of onychomycosis clinicaltrials.gov\/ct2\/show\/NCT03094468"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0101|cit101","first-page":"51","article-title":"Ideal properties of a modern antifungal agent--the therapy of mycoses with clotrimazole","volume":"50","author":"Oberste-Lehn","year":"1974","journal-title":"Postgraduate Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD012093.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/DSS.0000000000000189","article-title":"A 1,320-nm Nd: YAG laser for improving the appearance of onychomycosis","volume":"40","author":"Ortiz","year":"2014","journal-title":"Dermatologic Surgery"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD012093.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0190-9622(96)90053-5","article-title":"Clinical trials of the new antifungal drug therapies","volume":"34","author":"Rand","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2230.1992.tb00278.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly","volume":"17","author":"Reinel","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD012093.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/myc.12676","article-title":"Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis","volume":"60","author":"Schaller","year":"2017","journal-title":"Mycoses"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0106|cit106","first-page":"270","article-title":"Therapy of onychomycosis","volume":"8","author":"Schlockermann","year":"1957","journal-title":"Hautarzt"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09546634.2016.1151856","article-title":"An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis","volume":"27","author":"Shemer","year":"2016","journal-title":"Journal of Dermatological Treatment"},{"issue":"8","key":"10.1002\/14651858.CD012093.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1468-3083.2009.03547.x","article-title":"Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years","volume":"24","author":"Sigurgeirsson","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-0811","article-title":"Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial","volume":"90","author":"Sotiriou","year":"2010","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/abd1806-4841.20142197","article-title":"Distal and lateral toenail onychomycosis caused by trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye","volume":"89","author":"Souza","year":"2014","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jphotobiol.2015.03.015","article-title":"Small scale trial of photodynamic treatment of onychomycosis in Sao Paulo","volume":"150","author":"Tardivo","year":"2015","journal-title":"Journal of Photochemistry and Photobiology. B, Biology"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/myc.12037","article-title":"Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study","volume":"56","author":"Tietz","year":"2013","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012093.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/0926-9959(94)00076-C","article-title":"Amorolfine nail lacquer: Clinical experience in onychomycosis","volume":"4","author":"Zaug","year":"1995","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"18","key":"10.1002\/14651858.CD012093.pub2-BIB0114|cit114","first-page":"3288","article-title":"Long-pulse Nd:YAG 1064-nm laser treatment for onychomycosis","volume":"125","author":"Zhang","year":"2012","journal-title":"Chinese Medical Journal"},{"issue":"44","key":"10.1002\/14651858.CD012093.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"e5141","DOI":"10.1097\/MD.0000000000005141","article-title":"The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: A randomized, controlled trial","volume":"95","author":"Zhou","year":"2016","journal-title":"Medicine"},{"issue":"43","key":"10.1002\/14651858.CD012093.pub2-BIB0116|cit116","first-page":"52","article-title":"A frequently underestimated dermatomycosis. Long-term therapeutic success with fungicidal effect","volume":"144","author":"Anonymous","year":"2002","journal-title":"MMW Fortschritte der Medizin"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1977.01640030124032","article-title":"Topical therapy for onychomycosis","volume":"113","author":"Bagatell","year":"1977","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0118|cit118","first-page":"AB113","article-title":"Treatment of toenail DSO onychomycosis by T rubrum with topical 1% terbinafine gel","volume":"56","author":"Barquero","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0119|cit119","first-page":"50","article-title":"8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses","volume":"12","author":"Butareva","year":"1986","journal-title":"Vestnik Dermatologii i Venerologii"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0120|cit120","first-page":"144","article-title":"Clinical evaluation of a new antifungal agent clotrimazole in dermatomycoses","volume":"71","author":"Emokpare","year":"1977","journal-title":"Zeitschrift fur Arztliche Fortbildung (Jena)"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0121|cit121","unstructured":"EUCTR2008-002427-90 Double-blind study of the clinical and mycological equivalence of Loceryl\u00ae (Amorolfine, film-forming solution at 5%) and its generic in the treatment of onychomycosis without the nail matrix www.clinicaltrialsregister.eu\/ctr-search\/search?query=2008-002427-90"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0122|cit122","first-page":"134","article-title":"A comparison of three treatments for fungal nail infection","volume":"46","author":"George","year":"1991","journal-title":"British Journal of Podiatric Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7547\/87507315-64-3-158","article-title":"A further look at the treatment of onychomycosis with topical glutaraldehyde","volume":"64","author":"Grant","year":"1974","journal-title":"Journal of the American Podiatry Association"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0124|cit124","unstructured":"JPRN-JapicCTI-101143 A placebo-controlled, parallel group study of HTU-520 in patients with onychomycosis apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-JapicCTI-101143"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0125|cit125","first-page":"404","article-title":"A report on the clinical experiences from the comparison of the effectiveness of 0.2% and 0.5% solutions of the antimycotic agent VUFB 9244 (working name Jopargin)","volume":"51","author":"Klima","year":"1976","journal-title":"Ceskoslovenska Dermatologie"},{"issue":"42","key":"10.1002\/14651858.CD012093.pub2-BIB0126|cit126","first-page":"1308","article-title":"Local treatment of skin and nail mycoses with Daktarin, a new broad-spectrum antifungal agent. Testing results of a group of dermatologists in practice","volume":"61","author":"Kull","year":"1972","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0127|cit127","first-page":"266","article-title":"Clinical trial of Jadit in superficial mycoses","volume":"39","author":"Mathur","year":"1973","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0128|cit128","unstructured":"NCT00253305 Topical gel anti-fungal agent for tinea unguium clinicaltrials.gov\/ct2\/show\/NCT00253305"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0129|cit129","unstructured":"NCT02549001 Study to evaluate the efficacy and safety of P-3058 10% nail solution in the treatment of toenail onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT02549001"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5021\/ad.2017.29.6.699","article-title":"Randomized clinical trial to evaluate the efficacy and safety of combination therapy with short-pulsed 1,064-nm neodymium-doped yttrium aluminium garnet laser and amorolfine nail lacquer for onychomycosis","volume":"29","author":"Park","year":"2017","journal-title":"Annals of Dermatology"},{"issue":"9\/10","key":"10.1002\/14651858.CD012093.pub2-BIB0131|cit131","first-page":"335","article-title":"Loceryl nail lacquer - a new treatment of onychomycosis","volume":"20","author":"Ramm","year":"1994","journal-title":"Aktuelle Dermatologie"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0132|cit132","first-page":"425","article-title":"Treatment onychomycoses--bifonazole nail set in comparison with urea with ciclopiroxolamine formulation","volume":"87","author":"Ruping","year":"1993","journal-title":"Zeitschrift fur Arztliche Fortbildung"},{"issue":"20-21","key":"10.1002\/14651858.CD012093.pub2-BIB0133|cit133","first-page":"568","article-title":"Treatment of onychomycoses","volume":"69","author":"R\u00fcping","year":"1993","journal-title":"Zeitschrift f\u00fcr Allgemeinmedizin"},{"issue":"21","key":"10.1002\/14651858.CD012093.pub2-BIB0134|cit134","first-page":"887","article-title":"Clinical experience in the treatment of nail mycoses with the new antibiotic Bay b5097 (clotrimazol)","volume":"48","author":"Schubert","year":"1973","journal-title":"Zeitschrift fur Hautkrankheiten"},{"issue":"8","key":"10.1002\/14651858.CD012093.pub2-BIB0135|cit135","first-page":"1295","article-title":"Clotrimazol cream and solution--clinical assessment in an open trial","volume":"22","author":"Weuta","year":"1972","journal-title":"Arzneimittel-Forschung"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0136|cit136","first-page":"450","article-title":"Clinical efficacy of 0.3-ms pulsed 1,064 nm Nd:YAG laser for onychomycosis","volume":"46","author":"Xu","year":"2017","journal-title":"Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0137|cit137","first-page":"S338","article-title":"Clinical observation of the effects of focused ultrasound combined traditional Chinese medicine on neurodermatitis in middle and aged patients","volume":"64","author":"Yao","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0138|cit138","unstructured":"ACTRN12618000131257 Phase I, first in human (FIH), randomised, double-blind, placebo-controlled multiple ascending dose study in healthy volunteers with mild to moderate onychomycosis www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=374039"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0139|cit139","unstructured":"ChiCTR-INR-17013504 2940-nm Er:YAG fractional laser combined with amorolfine hydrochloride and amorolfine hydrochloride for treating onychomycosis: a prospective, randomized, controlled, evaluator-blinded, parallel-group clinical trial www.chictr.org.cn\/showproj.aspx?proj=23130"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0140|cit140","unstructured":"DRKS00007709 Treatment of onychomycosis with a short-pulsed Nd:YAG Laser (1064nm) apps.who.int\/trialsearch\/Trial2.aspx?TrialID=DRKS00007709"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0141|cit141","unstructured":"EUCTR2016-001204-39 A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO) www.clinicaltrialsregister.eu\/ctr-search\/search?query=2016-001204-39"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0142|cit142","unstructured":"EUCTR2016-003784-19 Phase III, multicentre, randomised, double-blind, parallel-group, clinical trial to evaluate the efficacy and safety of a new medicated nail lacquer for the treatment of toenail fungal infection www.clinicaltrialsregister.eu\/ctr-search\/search?query=2016-003784-19"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0143|cit143","unstructured":"JapicCTI-183840 A phase II multicenter, randomized, double-blind, vehicle-controlled, parallel-group study to investigate the efficacy and safety of ME1111 for 48 weeks of treatment in patients with mild to moderate onychomycosis www.clinicaltrials.jp\/user\/showCteDetailE.jsp?japicId=JapicCTI-183840"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0144|cit144","unstructured":"NCT02644551 The efficacy of CELEXT07 in the treatment of toenail onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT02644551"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0145|cit145","unstructured":"NCT02812043 Comparison between long-pulsed Nd:YAG, amorolfine and combination treatment in treating non-dermatophyte onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT02812043"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0146|cit146","unstructured":"NCT02859519 A multi-centre, double-blind, randomized, vehicle-controlled study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO) www.clinicaltrials.gov\/ct2\/show\/NCT02859519"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0147|cit147","unstructured":"NCT02866032 Study to evaluate the efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO) www.clinicaltrials.gov\/ct2\/show\/NCT02866032"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0148|cit148","unstructured":"NCT02961634 Study efficacy and safety in comparative use of investigational product adjuvant treatment in onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT02961634"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0149|cit149","unstructured":"NCT03098342 Comparison of efficacy and safety between methylene blue-mediated photodynamic therapy and 5% amorolfine nail lacquer for toenail onychomycosis treatment www.clinicaltrials.gov\/ct2\/show\/NCT03098342"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0150|cit150","unstructured":"NCT03814343 Topical amphotericin B in 30% dimethylsulphoxide in treating of non-dermatophytes onychomycosis www.clinicaltrials.gov\/ct2\/show\/NCT03814343"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0151|cit151","first-page":"891","article-title":"Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional-observational study","volume":"32","author":"Akkus","year":"2016","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"4596","key":"10.1002\/14651858.CD012093.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"524-7","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09546630701657187","article-title":"Review of antifungal therapy, part II: treatment rationale, including specific patient populations","volume":"19","author":"Baran","year":"2008","journal-title":"Journal of Dermatologic Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clindermatol.2010.07.008","article-title":"The nail in the elderly","volume":"29","author":"Baran","year":"2011","journal-title":"Clinics in Dermatology"},{"issue":"6 Suppl 2","key":"10.1002\/14651858.CD012093.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.2310\/7750.2006.00054","article-title":"Review of treatment for onychomycosis: consideration for special populations","volume":"10","author":"Barber","year":"2006","journal-title":"Journal of Cutaenous Medicine and Surgery"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1757-1146-7-34","article-title":"The effectiveness of lasers in the treatment of onychomycosis: a systematic review","volume":"7","author":"Bristow","year":"2014","journal-title":"Journal of Foot and Ankle Research"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0157|cit157","unstructured":"Centre for Evidence-Based Medicine Number needed to treat, 2014 www.cebm.net\/number-needed-to-treat-nnt\/"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2014.2983","article-title":"Treatment of nail psoriasis: best practice recommendations from the medical board of the National Psoriasis Foundation","volume":"151","author":"Crowley","year":"2015","journal-title":"JAMA Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0159|cit159","unstructured":"Cochrane Skin Core Outcomes Set Initiative (CS-COUSIN) skin.cochrane.org\/core-outcomes-set-initiative-csg-cousin"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0160|cit160","unstructured":"Dermik Laboratories Penlac Nail Lacquer (ciclopirox) Topical Solution 8% (Product insert) www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21022s004lbl.pdf"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0161|cit161","first-page":"515","article-title":"How to work with a subgroup analysis","volume":"52","author":"Dijkman","year":"2009","journal-title":"Canadian Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD012093.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"e3081","DOI":"10.1371\/journal.pone.0003081","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias","volume":"3","author":"Dwan","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4274\/turkderm.00908","article-title":"Evaluation of obesity-associated dermatoses in obese and overweight individuals","volume":"45","author":"D\u00f6ner","year":"2011","journal-title":"Turkderm"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0164|cit164","first-page":"626","article-title":"Onychomycosis: Does cure equate to treatment success?","volume":"15","author":"Elewski","year":"2016","journal-title":"Journal of Drugs in Dermatology"},{"issue":"65","key":"10.1002\/14651858.CD012093.pub2-BIB0165|cit165","first-page":"1","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"149","author":"Faergemann","year":"2003","journal-title":"British Journal of Dermatology, Suppl"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2340\/00015555-1576","article-title":"Onychomycosis as a warning sign for peripheral arterial disease","volume":"93","author":"Fukunaga","year":"2013","journal-title":"Acta Dermatology Venereology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0167|cit167","unstructured":"Galderma Loceryl Nail Lacquer (amorolfine) (Product insert) medicines.org.uk\/emc\/files\/pil.1411.pdf"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0168|cit168","unstructured":"McMaster University GRADEpro GDT 2015"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: an overview. Part II","volume":"30","author":"Gupta","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.1997.tb03673.x","article-title":"A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study","volume":"136","author":"Gupta","year":"1997","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD012093.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1365-4362.2000.00012.x","article-title":"Epidemiology and prevalence of onychomycosis in HIV-positive individuals","volume":"39","author":"Gupta","year":"2000","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2011.02.038","article-title":"Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment","volume":"66","author":"Gupta","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the treatment of onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clinics in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/13543784.2013.840289","article-title":"Investigational drugs for onychomycosis","volume":"23","author":"Gupta","year":"2014","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40257-014-0096-2","article-title":"Topical therapy for toenail onychomycosis: an evidence-based review","volume":"15","author":"Gupta","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1203475415581310","article-title":"Toenail onychomycosis-A Canadian approach with a new transungual treatment: Development of a clinical pathway","volume":"19","author":"Gupta","year":"2015","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000433473","article-title":"Network meta-analysis of onychomycosis treatments","volume":"1","author":"Gupta","year":"2015","journal-title":"Skin Appendage Disorders"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/09546634.2015.1066479","article-title":"The future of lasers in onychomycosis","volume":"27","author":"Gupta","year":"2016","journal-title":"Journal of Dermatological Treatment"},{"issue":"7","key":"10.1002\/14651858.CD012093.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/jdv.14212","article-title":"A critical review of improvement rates for laser therapy used to treat toenail onychomycosis","volume":"31","author":"Gupta","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","article-title":"Onychomycosis: a proposed revision of the clinical classification","volume":"65","author":"Hay","year":"2011","journal-title":"Journal of the American Academy Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0181|cit181","unstructured":"Higgins JP Deeks JJ Altman DJ Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0182|cit182","unstructured":"Higgins JP Altman DG Sterne JA. editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0183|cit183","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ editor(s) Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). The Cochrane Collaboration, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0184|cit184","unstructured":"Lipner SR Scher RK Part 1: Onychomycosis: Clinical overview and diagnosis Journal of the American Academy of Dermatology 10.1016\/j.jaad.2018.03.062"},{"issue":"4","key":"10.1002\/14651858.CD012093.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1346-8138.12020","article-title":"Frequency of peripheral arterial disease and venous insufficiency in toenail onychomycosis","volume":"40","author":"Ozkan","year":"2013","journal-title":"Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0187|cit187","first-page":"603","article-title":"Skin and nail mycoses in patients with diabetic foot","volume":"148","author":"Papini","year":"2013","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD012093.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.jaad.2008.06.015","article-title":"Photodynamic therapy of onychomycosis caused by Trichophyton rubrum","volume":"59","author":"Piraccini","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012093.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11592120-000000000-00000","article-title":"Health-related quality of life in patients with nail disorders","volume":"12","author":"Reich","year":"2011","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0191|cit191","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD012093.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/myc.12542","article-title":"Onychomycosis in patients with nail psoriasis: a point to point discussion","volume":"60","author":"Rigopoulos","year":"2017","journal-title":"Mycoses"},{"issue":"5832","key":"10.1002\/14651858.CD012093.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"213","author":"Rock","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0194|cit194","first-page":"223","article-title":"Onychomycosis: Epidemiology, diagnosis, and treatment in a changing landscape","volume":"14","author":"Rosen","year":"2015","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012093.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjon.2017.26.6.S6","article-title":"Foot ulceration in patients with diabetes: a risk analysis","volume":"26","author":"Rossaneis","year":"2017","journal-title":"British Journal of Nursing"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0196|cit196","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group. Version 3.0 December 2016 cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0197|cit197","unstructured":"Ryan R Synnot A Hill S Describing results. Cochrane Consumer and Communications Group. Version 2.0 December 2016 cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD012093.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jdv.12323","article-title":"The prevalence of onychomycosis in the global population: a literature study","volume":"28","author":"Siguregeirsson","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"10","key":"10.1002\/14651858.CD012093.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archderm.142.10.1279","article-title":"Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients","volume":"42","author":"Szepietowski","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000017990","article-title":"Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up","volume":"197","author":"Tosti","year":"1998","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0203|cit203","unstructured":"U.S. Food Drug Administration Medical Devices and Clinical Trial Design for the Treatment or Improvement in the Appearance of Fungally-Infected Nails - Draft Guidance for Industry and FDA Staff 2015 www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM431312.pdf"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0204|cit204","unstructured":"Valeant Bermuda Penlac\u00ae Nail Lacquer (ciclopirox) Topical Solution, 8% www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21022s004lbl.pdf"},{"key":"10.1002\/14651858.CD012093.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2147\/DDDT.S136986","article-title":"New insight into the pathogenesis of nail psoriasis and overview of treatment strategies","volume":"11","author":"Ventura","year":"2017","journal-title":"Drug Design, Development and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clindermatol.2009.12.006","article-title":"Onychomycosis","volume":"28","author":"Welsh","year":"2010","journal-title":"Clinics in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1972.01620050069017","article-title":"Onychomycosis","volume":"105","author":"Zaias","year":"1972","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012093.pub2-BIB0208|cit208","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001434.pub2","article-title":"Topical treatments for fungal infections of the skin and nails of the foot","author":"Crawford","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012093.pub2-BIB0209|cit209","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012093","article-title":"Topical and device-based treatments for fungal infections of the toenails","author":"Gupta","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012093.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T21:30:46Z","timestamp":1665610246000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012093.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":209,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012093.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]}}}